Understand the source comparison
Cerebrolysin Cognitive Function Protocol Comparison
Mild Cognitive Enhancement 5–10ml daily IM 10–20 days Age-related cognitive decline, memory consolidation 4–6 weeks for measurable improvement (MoCA +2 to +4 points) Low-dose protocols work for prevention. Higher doses don't accelerate mild improvement Stroke
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mild Cognitive Enhancement
- 5–10ml daily IM
- 10–20 days
- Age-related cognitive decline, memory consolidation
- 4–6 weeks for measurable improvement (MoCA +2 to +4 points)
- Low-dose protocols work for prevention. Higher doses don't accelerate mild improvement
- Stroke Recovery (Acute)
- 20–30ml daily IM
- 21 days, started within 48 hours
- Ischemic stroke, hemorrhagic stroke penumbra rescue
- 30–90 days for functional motor/speech recovery
- High-dose early intervention shows strongest effect. Delayed start loses efficacy
- Neurodegenerative Disease
- 10–20ml daily IM
- 20 days per cycle, 3–4 cycles/year
- Alzheimer's, vascular dementia, Parkinson's dementia
- Slowed decline vs untreated baseline, not reversal
- Quarterly cycles maintain function longer than single-course treatment
- Traumatic Brain Injury
- 20–30 days
- Post-concussion syndrome, moderate-severe TBI
- 60–120 days for cognitive recovery plateau
- Earlier initiation (within 7 days of injury) correlates with better long-term outcomes
- Cognitive Performance (Healthy)
- 5ml daily IM
- 10 days
- Learning enhancement, skill acquisition
- Variable. Dependent on concurrent cognitive demand
- Works only if paired with intensive practice. Passive use yields minimal benefit